Halsa Pharmaceuticals Receives $250,000 from Texas ETF to Develop . Therapeutic Weight-loss Treatment (InfoBolsa)

Therapeutic Weight-loss Treatment 24/03/2008 19:49:00 Business Wire Houston-based Halsa Pharmaceuticals, Inc., has been awarded $250,000 from the Texas Emerging Technology Fund (TETF) to continue development and pilot manufacturing of a therapeutic treatment for obesity.

No tags for this post.





Comments are closed.